Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2013 Filed Jun 3, 2013 22:58 UTC |
YOUNG JOHN DBusiness Unit President
|
GrantPhantom Stock Units SSP · Derivative | 57 | $27.23 | $1,552.11 |
DisclosureSEC source: 0001225208-13-013714 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 Underlying: Common Stock · 57 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:22 UTC |
BRANDICOURT OLIVIERBusiness Unit President
|
GrantPhantom Stock Units SSP · Derivative | 193 | $29.56 | $5,705.08 |
DisclosureSEC source: 0001225208-13-012560 · doc4.xml · derivative · entry 1 BRANDICOURT OLIVIER · CIK 0001508518 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,321 Underlying: Common Stock · 193 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:22 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 126 | $29.56 | $3,724.56 |
DisclosureSEC source: 0001225208-13-012561 · doc4.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,026 Underlying: Common Stock · 126 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 319 | $29.56 | $9,429.64 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · derivative · entry 22 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,084 Underlying: Common Stock · 319 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 14,497 | $29.30 | $424,762.10 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 20 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,682 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 14,248 | $29.32 | $417,751.36 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 19 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,179 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 11,706 | $29.35 | $343,571.10 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 18 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,427 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 10,913 | $29.33 | $320,078.29 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 17 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,133 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 8,106 | $29.34 | $237,830.04 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 16 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,046 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 6,342 | $29.41 | $186,518.22 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 15 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,152 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 5,693 | $29.31 | $166,861.83 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 14 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,494 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 5,103 | $29.36 | $149,824.08 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 13 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,187 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 4,745 | $29.29 | $138,981.05 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 12 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,290 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 3,500 | $29.39 | $102,865.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 11 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,035 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,700 | $29.40 | $79,380.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 10 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,535 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,447 | $29.27 | $71,623.69 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 9 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,235 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,400 | $29.25 | $70,200.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 8 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 575,682 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,400 | $29.37 | $70,488.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578,082 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,200 | $29.23 | $64,306.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 6 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,482 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 1,700 | $29.26 | $49,742.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 5 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,682 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 900 | $29.28 | $26,352.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 4 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 584,382 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 200 | $29.24 | $5,848.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,282 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 100 | $29.38 | $2,938.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,482 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:24 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 100 | $29.42 | $2,942.00 |
DisclosureSEC source: 0001225208-13-012562 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,582 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:30 UTC |
Dolsten MikaelPresident R&D
|
GrantPhantom Stock Units SSP · Derivative | 107 | $29.56 | $3,162.92 |
DisclosureSEC source: 0001225208-13-012563 · doc4.xml · derivative · entry 1 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,231 Underlying: Common Stock · 107 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:30 UTC |
HILL CHARLES HExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 53 | $29.56 | $1,566.68 |
DisclosureSEC source: 0001225208-13-012564 · doc4.xml · derivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010 Underlying: Common Stock · 53 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:30 UTC |
Germano Geno JBusiness Unit President
|
GrantPhantom Stock Units SSP · Derivative | 117 | $29.56 | $3,458.52 |
DisclosureSEC source: 0001225208-13-012565 · doc4.xml · derivative · entry 1 Germano Geno J · CIK 0001424383 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,415 Underlying: Common Stock · 117 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:37 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 56 | $29.56 | $1,655.36 |
DisclosureSEC source: 0001225208-13-012566 · doc4.xml · derivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,203 Underlying: Common Stock · 56 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:37 UTC |
Lewis-Hall Freda CExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 148 | $29.56 | $4,374.88 |
DisclosureSEC source: 0001225208-13-012567 · doc4.xml · derivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,761 Underlying: Common Stock · 148 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:37 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 508 | $29.56 | $15,016.48 |
DisclosureSEC source: 0001225208-13-012568 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,676 Underlying: Common Stock · 508 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 16, 2013 23:37 UTC |
OLSON LAURIE JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 36 | $29.56 | $1,064.16 |
DisclosureSEC source: 0001225208-13-012569 · doc4.xml · derivative · entry 1 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173 Underlying: Common Stock · 36 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 1,446 | $29.56 | $42,743.76 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · derivative · entry 21 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,135 Underlying: Common Stock · 1,446 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 19,400 | $29.48 | $571,912.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 18 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,463 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 10,503 | $29.30 | $307,737.90 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 17 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,080,863 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 8,700 | $29.36 | $255,432.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 16 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,091,366 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 6,500 | $29.41 | $191,165.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 15 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,066 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 4,800 | $29.39 | $141,072.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 14 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106,566 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 3,791 | $29.31 | $111,114.21 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 13 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,366 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 3,102 | $29.34 | $91,012.68 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 12 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115,157 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 2,900 | $29.35 | $85,115.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 11 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118,259 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 2,900 | $29.40 | $85,260.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 10 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121,159 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 1,800 | $29.37 | $52,866.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 9 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,059 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 1,302 | $29.33 | $38,187.66 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125,859 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 1,297 | $29.29 | $37,989.13 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 7 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,127,161 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 900 | $29.46 | $26,514.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 6 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,458 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 705 | $29.32 | $20,670.60 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 5 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,129,358 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 700 | $29.47 | $20,629.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 4 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130,063 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 200 | $29.38 | $5,876.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130,763 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 200 | $29.42 | $5,884.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130,963 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
| May 15, 2013 Filed May 17, 2013 00:10 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 200 | $29.49 | $5,898.00 |
DisclosureSEC source: 0001225208-13-012576 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,163 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.